Comments
Loading...
Sigyn Therapeutics Analyst Ratings and Price Targets | OTC:SIGY | Benzinga
Sigyn Therapeutics Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Sigyn Therapeutics Corp from these most-recent analyst ratings.
Analyst Ratings for Sigyn Therapeutics
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Sigyn Therapeutics (SIGY) stock?
There is no price target for Sigyn Therapeutics
What is the most recent analyst rating for Sigyn Therapeutics (SIGY)?
There is no analyst for Sigyn Therapeutics
When was the last upgrade for Sigyn Therapeutics (SIGY)?
There is no last upgrade for Sigyn Therapeutics
When was the last downgrade for Sigyn Therapeutics (SIGY)?
There is no last downgrade for Sigyn Therapeutics.
When is the next analyst rating going to be posted or updated for Sigyn Therapeutics (SIGY)?
There is no next analyst rating for Sigyn Therapeutics.
Is the Analyst Rating Sigyn Therapeutics (SIGY) correct?
There is no next analyst rating for Sigyn Therapeutics.
Browse analyst ratings and price targets on all stocks.
